Live Feeds
● LIVE Updated 7d ago · 32 sources tracked

Popular weight-loss drugs linked to unexpected male fertility benefit

Research presented at the Endocrine Society annual meeting in Chicago suggests GLP-1 medications may improve male fertility in obese men. These drugs are associated with better sperm quality and higher testosterone levels. One in 8 Americans currently use GLP-1 drugs for weight loss.

RSS Source map (35)

What changed

New data indicates that one in 8 Americans use these medications and confirms the findings were presented at the Endocrine Society annual meeting.

Live updates

  1. GLP-1 Weight-Loss Drugs Linked to Male Fertility Benefits

    Research presented at the Endocrine Society annual meeting in Chicago suggests GLP-1 medications may improve male fertility in obese men. These drugs are associated with better sperm quality and higher testosterone levels. One in 8 Americans currently use GLP-1 drugs for weight loss.

    What's confirmed:

    • Research presented at the Endocrine Society annual meeting in Chicago indicates GLP-1 weight loss medications may improve male fertility.
    • GLP-1 medications are linked to improved sperm quality and increased testosterone levels in obese men.

    Still unconfirmed:

    • One in 8 Americans are taking a GLP-1 for weight loss.
    • Doctors state that reversing low testosterone levels is an unintended benefit of these drugs.
    • The largest observational study of GLP-1 weight-loss drugs suggests benefits could be wide-ranging but include risks.
    confidence 90%

  2. GLP-1 Weight-Loss Drugs Linked to Improved Male Fertility

    New research indicates that GLP-1 medications may enhance male fertility in obese men. These drugs are linked to increased testosterone levels and improved sperm quality. Experts presented these findings at the ENDO 2026 annual meeting in Chicago.

    What's confirmed:

    • GLP-1 medications such as semaglutide and liraglutide may boost fertility in obese men.
    • These weight-loss drugs are linked to increased testosterone and improved sperm quality.
    • Research on this topic was presented at the ENDO 2026 annual meeting of the Endocrine Society in Chicago.
    • Obesity is strongly linked to male fertility problems and can cause dysregulation of the hypothalamic-pituitary-gonadal axis.
    • GLP-1 drugs do not appear to suppress male hormones.

    Still unconfirmed:

    • Testosterone levels normalise in 77% of men after obesity drug treatment.
    • GLP-1 use during early pregnancy may not increase risk of major adverse outcomes.
    confidence 90%